 | Up a level |
Stucki, A; Cottagnoud, M; Acosta, F; Egerman, U; Laeuffer, JM; Cottagnoud, P (2012). Efficacy of doripenem against escherichia coli and klebsiella pneumoniae in experimental meningitis. Journal of antimicrobial chemotherapy, 67((3)), pp. 661-5. Oxford: Oxford University Press 10.1093/jac/dkr482
Helbling, A; Ballmer-Weber, B; Cottagnoud, P (2009). Der besondere Fall - Soja-Allergie: Die leise Gefahr in Nahrungszusatzmitteln. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(38), pp. 679-81. Basel: EMH Editores Medicorum Helveticorum
Schmidtko, J; Truninger, K; Gugger, M; Cottagnoud, P; Stucki, A (2008). Was ist Ihre Diagnose? Diaphragma Disease. Praxis - schweizerische Rundschau für Medizin, 97(3), pp. 117-8. Bern: Huber
Vetter, Ch; Robert-Tissot, L; Cottagnoud, P; Stucki, A (2008). [Working under pressure]. Praxis - schweizerische Rundschau für Medizin, 97(8), pp. 437-42. Bern: Huber
Stucki, A; Cottagnoud, M; Winkelmann, V; Schaffner, T; Cottagnoud, P (2007). Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrobial agents and chemotherapy, 51(6), pp. 2249-52. Washington, D.C.: American Society for Microbiology 10.1128/AAC.01000-06
Chatterjee, B; Cottagnoud, P; Einbock, W; Stucki, A (2007). [What is your diagnosis? Hypertensive retinopathy grade 3]. Praxis - schweizerische Rundschau für Medizin, 96(3), pp. 51-2. Bern: Huber
Hohl, A; Vogel, C; Cottagnoud, P; Stanga, Z; Chatterjee, B; Stucki, A (2007). [A rare case of secondary hypertension]. Praxis - schweizerische Rundschau für Medizin, 96(18), pp. 739-41. Bern: Huber
Stucki, A; Stanga, Z; Cottagnoud, P; Einbock, W (2006). [What is your diagnosis? Diabetic retinopathy]. Praxis - schweizerische Rundschau für Medizin, 95(39), pp. 1487-8. Bern: Huber
Stucki, A; Stanga, Z; Cottagnoud, P; Trittibach, P (2006). [What is your diagnosis? Episcleritis. Observing the disease course]. Praxis - schweizerische Rundschau für Medizin, 95(49), pp. 1911-2. Bern: Huber
Hofmann, M; Richter, J; Stanga, Z; Wermelinger, F; Cottagnoud, P; Kobel, D; Stucki, A (2006). [What is your diagnosis? Acute gout attack]. Praxis - schweizerische Rundschau für Medizin, 95(48), pp. 1871-2. Bern: Huber
Richter, J C; Fischli, S; Schiemann, U; Birrenbach, T; Gugger, M; Cottagnoud, P; Stucki, A (2006). [Eosinophilia, diarrhea and asthma in a young woman]. Praxis - schweizerische Rundschau für Medizin, 95(3), pp. 71-6. Bern: Huber
Ozimek, A; Chatterjee, B; Stanga, Z; Cottagnoud, P; Stucki, A (2006). [36 year-old patient with multiple hypodense splenic lesions]. Praxis - schweizerische Rundschau für Medizin, 95(49), pp. 1931-3. Bern: Huber 10.1024/1661-8157.95.49.1931
Iff, S; Stanga, Z; Würmli-Gloor, B; Cottagnoud, P; Stucki, A (2006). [What is your diagnosis? Tongue diseases]. Praxis - schweizerische Rundschau für Medizin, 95(45), pp. 1749-50. Bern: Huber 10.1024/1661-8157.95.45.1749
Willenberg, T; Stanga, Z; Cottagnoud, P; Stucki, A (2006). [What is your diagnosis? Pyoderma grangrenosum]. Praxis - schweizerische Rundschau für Medizin, 95(43), pp. 1661-2. Bern: Huber
Willenberg, T; Cottagnoud, P; Stanga, Z; Stucki, A (2006). [What is your diagnosis? Varicella zoster primary infection]. Praxis - schweizerische Rundschau für Medizin, 95(33), pp. 1215-6. Bern: Huber 10.1024/0369-8394.95.33.1215
Willenberg, T; Stanga, Z.; Cottagnoud, P; Stucki, A (2006). [What is your diagnosis? Erythema migrans ("Bull Eye"). Initial stage of Lyme borreliosis]. Praxis - schweizerische Rundschau für Medizin, 95(21), pp. 837-8. Bern: Huber 10.1024/0369-8394.95.21.837
Binder, R K; Stanga, Z; Cottagnoud, P; Stucki, A (2006). [What is your diagnosis? The examination shows peripheral facial paresis]. Praxis - schweizerische Rundschau für Medizin, 95(13), pp. 481-2. Bern: Huber 10.1024/0369-8394.95.13.481
Ozimek, A; Fischli, S; Vetter, C; Stanga, Z; Cottagnoud, P; Stucki, A (2006). [84 year old pensioner with progredient sensomotoric deficits]. Praxis - schweizerische Rundschau für Medizin, 95(9), pp. 331-4. Bern: Huber 10.1024/0369-8394.95.9.331
Binder, R; Stanga, Z; Cottagnoud, P; Stucki, A (2006). [What is your diagnosis? Bisalbuminemia]]. Praxis - schweizerische Rundschau für Medizin, 95(6), pp. 181-2. Bern: Huber 10.2460/javma.237.2.155
Stucki, A; Bürki, S; Stonga, Z; Cottagnoud, P (2006). [Exercise-induced asthma (EIA) Synonym; Exercise-induced bronchoconstriction (EIB)]. Praxis - schweizerische Rundschau für Medizin, 95(34), pp. 1265-6. Bern: Huber
Stucki, A; Cottagnoud, P; Fischli, S (2005). [Rare cause of right heart failure: two cases]. Deutsche medizinische Wochenschrift, 130(21), pp. 1314-7. Stuttgart: Thieme 10.1055/s-2005-868726
Fischli, S; Gassmann, Ch; Stanga, Z; Cottagnoud, P; Stucki, A (2004). [Dyspnea and hemoptysis in a young woman with unclear renal alterations]. Praxis - schweizerische Rundschau für Medizin, 93(46), pp. 1923-8. Bern: Huber 10.1024/0369-8394.93.46.1923
Cottagnoud, P; Gerber, CM; Majcherczyk, PA; Acosta, F; Cottagnoud, M; Neftel, K; Moreillon, P; Täuber, MG (2003). The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Infection and immunity, 71(6), pp. 3663-6. New York, N.Y.: American Society for Microbiology 10.1128/IAI.71.6.3663-3666.2003
Cottagnoud, P; Pfister, M; Cottagnoud, M; Acosta, F; Täuber, MG (2003). Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 47(6), pp. 1943-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.6.1943-1947.2003
Cottagnoud, P; Cottagnoud, M; Täuber, MG (2003). Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrobial agents and chemotherapy, 47(1), pp. 144-7. Washington, D.C.: American Society for Microbiology 10.1128/ACC.47.1.144-147.2003
Pfister, M; Zhang, L; Hammarlund-Udenaes, M; Sheiner, LB; Gerber, CM; Täuber, MG; Cottagnoud, P (2003). Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin. Antimicrobial agents and chemotherapy, 47(1), pp. 138-43. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.1.138-143.2003
Cottagnoud, P; Täuber, MG (2003). Fluoroquinolones in the Treatment of Meningitis. Current infectious disease reports, 5(4), pp. 329-336. Philadelphia, Pa.: Current Science 10.1007/s11908-003-0011-0
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(5), pp. 1607-9. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.5.1607-1609-2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Journal of antimicrobial chemotherapy, 49(2), pp. 327-30. Oxford: Oxford University Press 10.1093/jac/49.2.327
Cottagnoud, P; Gerber, CM; Cottagnoud, M; Täuber, MG (2002). Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 46(1), pp. 188-90. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.188-190.2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Pfister, M; Täuber, MG (2002). Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(1), pp. 184-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.184-187.2002
Cottagnoud, P; Entenza, JM; Cottagnoud, M; Que, YA; Moreillon, P; Taüber, MG (2001). Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC microbiology, 1(1), p. 9. London: BioMed Central 10.1186/1471-2180-1-9
Perrig, M; Acosta, F; Cottagnoud, M; Gerber, CM; Täuber, MG; Cottagnoud, P (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 47(5), pp. 701-4. Oxford: Oxford University Press 10.1093/jac/47.5.701
Cottagnoud, P; Gerber, CM; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(6), pp. 981-5. Oxford: Oxford University Press 10.1093/jac/46.6.981
Gerber, CM; Tovar, L; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (2000). Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(2), pp. 249-53. Oxford: Oxford University Press 10.1093/jac/46.2.249
Cottagnoud, P; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrobial agents and chemotherapy, 44(8), pp. 2179-81. Washington, D.C.: American Society for Microbiology 10.1128/AAC.44.8.2179-2181.2000
Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (2000). Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 45(1), pp. 63-8. Oxford: Oxford University Press 10.1093/jac/45.1.63
Gerber, CM; Cottagnoud, M; Neftel, KA; Täuber, MG; Cottagnoud, P (1999). Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. European journal of clinical microbiology & infectious diseases, 18(12), pp. 866-70. Berlin: Springer 10.1007/s100960050421
Rodoni, D; Hänni, F; Gerber, CM; Cottagnoud, M; Neftel, K; Täuber, MG; Cottagnoud, P (1999). Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrobial agents and chemotherapy, 43(4), pp. 963-5. Washington, D.C.: American Society for Microbiology
